A Guide for Choosing the Right Immuno-Oncology CRO

Mitigating Risk in the Clinic

Rapid advances in immuno-oncology treatments have fueled a tremendous investment in this promising area of research.

To mitigate risk, it’s critical for sponsors and investigators — and everyone else working on your immuno-oncology study – to understand how the immune system responds to cancer treatments along with the additional operational complexities that result from it.

A Guide for Choosing the Right Immuno-Oncology CRO provides recommendations in eight key areas to prevent your immuno-oncology study from getting off track:

  • Site Selection
  • Investigational Product Handling
  • Biosample Collection
  • Product Storage
  • Monitoring irAEs and SAEs in Immuno-Oncology Studies
  • SAE and irAE Management
  • Specialized Report Forms
  • CRF Guidelines

This guide was developed from our hands-on experience managing complex immuno-oncology studies since 2008. Download >>>

If you’d like to talk about your upcoming immuno-oncology study, connect with us.

Download the Guide!

The content in this guide is designed for CMOs, VPs and Directors of Clinical Development, the clinical operations team and any others involved in designing and managing immuno-oncology studies.


Immuno-Oncology CRO